The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles
Abstract
Oxygen heterocycles are the second most common type of heterocycles that appear as structural components of U.S. Food and Drug Administration (FDA) approved pharmaceuticals. Analysis of our database of drugs approved through 2017 reveals 311 distinct pharmaceuticals containing at least one oxygen heterocycle. Most prevalent among these are pyranoses, with furanoses, macrolactones, morpholines, and dioxolanes rounding off the top five. The main body of this Perspective is organized according to ring size, commencing with three- and four-membered rings and ending with macrocycles, polymers, and unusual oxygen-containing heterocycles. For each section, all oxygen heterocycle-containing drugs are presented along with a brief discussion about structural and drug application patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Self-citationIlardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Self-citationMycophenolate mofetil and its mechanisms of action
Allison, A. C., & Eugui, E. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00188-0 · Cited by 1,433
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives
McGrath, N. A., Brichacek, M., & Njardarson, J. T. (2010) · Journal of Chemical Education · doi:10.1021/ed1003806 · Cited by 1,188
Self-citationHyaluronic acid: A key molecule in skin aging
Papakonstantinou, E., Roth, M., & Karakiulakis, G. (2012) · Dermato-Endocrinology · doi:10.4161/derm.21923 · Cited by 1,031
Anthracycline Chemotherapy and Cardiotoxicity
McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6711-0 · Cited by 956
Artemisinin: mechanisms of action, resistance and toxicity
Meshnick, S. R. (2002) · International Journal for Parasitology · doi:10.1016/s0020-7519(02)00194-7 · Cited by 720
IMMUNOPHARMACOLOGY OF RAPAMYCIN
Abraham, R. T., & Wiederrecht, G. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.483 · Cited by 653
Oxadiazoles in Medicinal Chemistry
Boström, J., Hogner, A., Llinàs, A., Wellner, E., & Plowright, A. T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2013248 · Cited by 614
Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond, É., Faivre, S. J., WOYNAROWSKI, J. M., & Chaney, S. G. (1998) · PubMed · Cited by 520
Auranofin: Repurposing an Old Drug for a Golden New Age
Roder, C., & Thomson, M. J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0083-y · Cited by 497
Eteplirsen in the treatment of Duchenne muscular dystrophy
Lim, K. R., Maruyama, R., & Yokota, T. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s97635 · Cited by 495
Eleazu, C. O., Eleazu, K. C., Chukwuma, S., & Essien, U. N. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-60 · Cited by 459
Oxetanes in Drug Discovery: Structural and Synthetic Insights
Wuitschik, G., Carreira, E. M., Wagner, B., Fischer, H., Parrilla, I., Schuler, F., Rogers-Evans, M., & Müller, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018788 · Cited by 418
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances: Miniperspective
Reis, J., Gaspar, A., Milhazes, N., & Borges, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01720 · Cited by 414
Indolocarbazole natural products: occurrence, biosynthesis, and biological activity
Sánchez, C., Méndez, C., & Salas, J. A. (2006) · Nat. Prod. Rep. · doi:10.1039/b601930g · Cited by 407
Oxazolidinones: activity, mode of action, and mechanism of resistance
Bozdogan, B., & Appelbaum, P. C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.003 · Cited by 403
Galantamine: A Review of its Use in Alzheimer??s Disease
Scott, L. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060050-00008 · Cited by 383
Ivermectin, 'Wonder drug' from Japan: the human use perspective
CRUMP, A., & OMURA, S. (2011) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.87.13 · Cited by 368
Introduction: The History of Arsenic Trioxide in Cancer Therapy
Antman, K. H. (2001) · The Oncologist · doi:10.1634/theoncologist.6-suppl_2-1 · Cited by 355
VanderMolen, K. M., McCulloch, W., Pearce, C. J., & Oberlies, N. H. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.35 · Cited by 333
Anderson, M. A., Deng, J., Seymour, J. F., Tam, C., Kim, S. Y., Fein, J., Yu, L., Brown, J. R., Westerman, D., Si, E. G., et al. (2016) · Blood · doi:10.1182/blood-2016-01-688796 · Cited by 316
Ashcroft, D. M., Dimmock, P., Garside, R., Stein, K., & Williams, H. C. (2005) · BMJ · doi:10.1136/bmj.38376.439653.d3 · Cited by 294
Posaconazole: a broad-spectrum triazole antifungal
Torres, H. A., Hachem, R. Y., Chemaly, R. F., Kontoyiannis, D. P., & Raad, I. I. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70297-8 · Cited by 285
Hadváry, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52203-1 · Cited by 280
Treatment of Nightmares With Prazosin: A Systematic Review
Kung, S., Espinel, Z., & Lapid, M. I. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.05.015 · Cited by 277
The use of vancomycin with its therapeutic and adverse effects: a review.
Bruniera, F. R., Ferreira, F. M., Saviolli, L. R. M., Bacci, M. R., Feder, D., Pedreira, M. D. L. G., Peterlini, M. A. S., Azzalis, L. A., Junqueira, V. B. C., & Fonseca, F. L. A. (2015) · PubMed · Cited by 275
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
Hauptman, P. J., & Kelly, R. A. (1999) · Circulation · doi:10.1161/01.cir.99.9.1265 · Cited by 268
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Nair, S., & Wilding, J. P. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0473 · Cited by 263
Grynkiewicz, G., & Gadzikowska, M. (2008) · PubMed · Cited by 241
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
Corey, D. R. (2017) · Nature Neuroscience · doi:10.1038/nn.4508 · Cited by 240
An update on β-lactamase inhibitor discovery and development
Docquier, J.-D., & Mangani, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2017.11.002 · Cited by 220
Benzofuran: an emerging scaffold for antimicrobial agents
Hiremathad, A., Patil, M. R., K. R., C., Chand, K., Santos, M. A., & Keri, R. S. (2015) · RSC Advances · doi:10.1039/c5ra20658h · Cited by 216
Aminoglycoside antibiotics: old drugs and new therapeutic approaches
Hermann, T. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7034-x · Cited by 213
Anticoagulants: A Review of the Pharmacology, Dosing, and Complications
Alquwaizani, M., Buckley, L., Adams, C., & Fanikos, J. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-013-0014-6 · Cited by 201
Moy, B., Kirkpatrick, P. N., Kar, S., & Goss, P. E. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2332 · Cited by 180
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
Kim, K. B., & Crews, C. M. (2013) · Natural Product Reports · doi:10.1039/c3np20126k · Cited by 175
Crooke, S. T., & Geary, R. S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04469.x · Cited by 171
2-Deoxystreptamine: Central Scaffold of Aminoglycoside Antibiotics
Busscher, G. F., Rutjes, F. P. J. T., & van Delft, F. L. (2005) · Chemical Reviews · doi:10.1021/cr0404085 · Cited by 169
16-membered macrolide antibiotics: a review
Arsic, B., Barber, J., Čikoš, A., Mladenovic, M., Stankovic, N., & Novak, P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.020 · Cited by 165
Elewski, B. E., Aly, R., Baldwin, S. L., González Soto, R. F., Rich, P., Weisfeld, M., Wiltz, H., Zane, L. T., & Pollak, R. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.010 · Cited by 164
Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV
Kandel, C., & Walmsley, S. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s84850 · Cited by 159
Camptothecin and its analogues: a review on their chemotherapeutic potential
Sriram, D., Yogeeswari, P., Thirumurugan, R., & Bal, T. R. (2005) · Natural Product Research · doi:10.1080/14786410412331299005 · Cited by 153
The treatment of influenza with antiviral drugs.
Stiver, G. (2003) · Europe PMC (PubMed Central) · Cited by 152
Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
Seto, B. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-29 · Cited by 149
Sánchez, C. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_295.x · Cited by 144
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
Schade, S., & Paulus, W. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv102 · Cited by 135
The Role of Acarbose in the Treatment of Non–Insulin-Dependent Diabetes Mellitus
Hanefeld, M. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00123-2 · Cited by 129
Pasha, M. K., Syed, M., Shaik, J. S., Shashikumar, D., Mullangi, R., & Srinivas, N. R. (2005) · Biomedical Chromatography · doi:10.1002/bmc.561 · Cited by 110
Anderson, V. R., & Perry, C. M. (2006) · Drugs · doi:10.2165/00003495-200666060-00006 · Cited by 104
Structure and Mechanism of the Lincosamide Antibiotic Adenylyltransferase LinB
Morar, M., Bhullar, K., Hughes, D. W., Junop, M. S., & Wright, G. D. (2009) · Structure · doi:10.1016/j.str.2009.10.013 · Cited by 94
Goodwin, K. D., Lewis, M. A., Long, E. C., & Georgiadis, M. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708143105 · Cited by 84
Snyder, D. E., Meyer, J. A., Zimmermann, A. G., Qiao, M., Gissendanner, S. J., Cruthers, L. R., Slone, R. L., & Young, D. R. (2007) · Veterinary Parasitology · doi:10.1016/j.vetpar.2007.09.011 · Cited by 80
Drug discovery targeting the mTOR pathway
Martelli, A. M., Buontempo, F., & McCubrey, J. A. (2018) · Clinical Science · doi:10.1042/cs20171158 · Cited by 80
Crisaborole and its Potential Role in Treating Atopic Dermatitis: Overview of Early Clinical Studies
Zane, L. T., Chanda, S., Jarnagin, K., Nelson, D., Spelman, L. J., & Gold, L. S. (2016) · Immunotherapy · doi:10.2217/imt-2016-0023 · Cited by 77
Oral Vitamin B12 Replacement for the Treatment of Pernicious Anemia
Chan, C. Q. H., Low, L. L., & Lee, K. H. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00038 · Cited by 70
Mechanism of Action of Cerulenin on Fatty Acid Synthetase.1
Kawaguchi, A., Tomoda, H., Nozoe, S., ŌMURA, S., & Okuda, S. (1982) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133933 · Cited by 69
Use of aromatase inhibitors to increase final height
Dunkel, L. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.031 · Cited by 68
Tambo, E., Khater, E. I. M., Chen, J., Bergquist, R. N., & Zhou, X. (2015) · Infectious Diseases of Poverty · doi:10.1186/s40249-015-0091-8 · Cited by 63
Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer
McBride, A., & Butler, S. K. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110237 · Cited by 62
Ford, N. P., Shubber, Z., Hill, A. M., Vitória, M., Doherty, M. C., Mills, E. J., & Gray, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079981 · Cited by 41
Importance of the lactonic ring in the activity of steroidal antialdosterones
Peterfalvi, M., TORELLI, V., FOURNEX, R., Rousseau, G. G., Claire, M., Michaud, A., & Corvol, P. L. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90513-4 · Cited by 25
Chen, X., Zhai, X., Kang, Z., & Sun, X. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-3 · Cited by 23
Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis C
Voaklander, R., & Jacobson, I. M. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1351295 · Cited by 23
Yasuda, H., & Niki, H. (2002) · Clinical Drug Investigation · doi:10.2165/00044011-200222020-00001 · Cited by 21
Cited by
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
Photocatalytic Late-Stage C–H Functionalization
Bellotti, P., Huang, H.-M., Faber, T., & Glorius, F. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00478 · Cited by 623
A Survey of the Structures of US FDA Approved Combination Drugs
Das, P., Delost, M. D., Qureshi, M. H., Smith, D. T., & Njardarson, J. T. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01610 · Cited by 312
Self-citationA structural analysis of the FDA green book-approved veterinary drugs and roles in human medicine
Scott, K. A., Qureshi, M. H., Cox, P. B., Marshall, C. M., Bellaire, B. C., Wilcox, M., Stuart, B. A. R., & Njardarson, J. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01502 · Cited by 56
Self-citation
Metadata
- Authors
- Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-07-19
- Volume
- 61
- Issue
- 24
- Pages
- 10996-11020
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2883457812
- Cited by
- 409
- References
- 67
- FWCI
- 18.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.